Gene · 29978
Papers1,439
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,439
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| UBQLN2 and HSP70 participate in Parkin-mediated mitophagy by facilitating outer mitochondrial membrane rupture. | EMBO Rep | 2023 | 37501540 | PubTator, text mining | PubMed |
| CRISPR/Cas9: implication for modeling and therapy of amyotrophic lateral sclerosis. | Front Neurosci | 2023 | 37483353 | PubTator, text mining | PubMed |
| Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis. | Int J Mol Sci | 2023 | 37445986 | PubTator, text mining | PubMed |
| UBQLN Family Members Regulate MYC in Lung Adenocarcinoma Cells. | Cancers (Basel) | 2023 | 37444499 | PubTator, text mining | PubMed |
| Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives. | Iran J Basic Med Sci | 2023 | 37427325 | PubTator, text mining | PubMed |
| Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies. | Acta Neuropathol Commun | 2023 | 37415197 | PubTator, text mining | PubMed |
| Characterizing proteomic and transcriptomic features of missense variants in amyotrophic lateral sclerosis genes. | Brain | 2023 | 37394881 | PubTator, text mining | PubMed |
| Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder. | Biomedicines | 2023 | 37371694 | PubTator, text mining | PubMed |
| HnRNP Pathologies in Frontotemporal Lobar Degeneration. | Cells | 2023 | 37371103 | PubTator, text mining | PubMed |
| The identification of high-preforming antibodies for Ubiquilin-2 for use in Western Blot, immunoprecipitation, and immunofluorescence. | F1000Res | 2023 | 37359784 | PubTator, text mining | PubMed |
| Deciphering molecular mechanisms of phase separation in RNA biology by single-molecule biophysical technologies. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37337634 | PubTator, text mining | PubMed |
| A Novel PSEN1 Variant Leading to Posterior Cortical Atrophy: A Case Report. | J Alzheimers Dis Rep | 2023 | 37313494 | PubTator, text mining | PubMed |
| Astrocytes: Dissecting Their Diverse Roles in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. | Cells | 2023 | 37296571 | PubTator, text mining | PubMed |
| The pros and cons of ubiquitination on the formation of protein condensates. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37294105 | PubTator, text mining | PubMed |
| Ion Mobility Mass Spectrometry Unveils Global Protein Conformations in Response to Conditions that Promote and Reverse Liquid-Liquid Phase Separation. | J Am Chem Soc | 2023 | 37276246 | PubTator, text mining | PubMed |
| Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration. | Acta Neuropathol Commun | 2023 | 37264457 | PubTator, text mining | PubMed |
| Intranasal Lipid Nanoparticles Containing Bioactive Compounds Obtained from Marine Sources to Manage Neurodegenerative Diseases. | Pharmaceuticals (Basel) | 2023 | 37259454 | PubTator, text mining | PubMed |
| Looking for answers far away from the soma-the (un)known axonal functions of TDP-43, and their contribution to early NMJ disruption in ALS. | Mol Neurodegener | 2023 | 37259156 | PubTator, text mining | PubMed |
| Wild-type and pathogenic forms of ubiquilin 2 differentially modulate components of the autophagy-lysosome pathways. | J Pharmacol Sci | 2023 | 37257946 | PubTator, text mining | PubMed |
| Recent progress of the genetics of amyotrophic lateral sclerosis and challenges of gene therapy. | Front Neurosci | 2023 | 37250416 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/29978/papers?page=6